201 related articles for article (PubMed ID: 26095617)
21. miR-150, p53 protein and relevant miRNAs consist of a regulatory network in NSCLC tumorigenesis.
Wang DT; Ma ZL; Li YL; Wang YQ; Zhao BT; Wei JL; Qi X; Zhao XT; Jin YX
Oncol Rep; 2013 Jul; 30(1):492-8. PubMed ID: 23670238
[TBL] [Abstract][Full Text] [Related]
22. MicroRNAs in personalized cancer therapy.
Sethi S; Ali S; Sethi S; Sarkar FH
Clin Genet; 2014 Jul; 86(1):68-73. PubMed ID: 24635652
[TBL] [Abstract][Full Text] [Related]
23. MicroRNAs and SerpinB3 in hepatocellular carcinoma.
Turato C; Simonato D; Quarta S; Gatta A; Pontisso P
Life Sci; 2014 Mar; 100(1):9-17. PubMed ID: 24496037
[TBL] [Abstract][Full Text] [Related]
24. microRNA expression in the eyes and their significance in relation to functions.
Xu S
Prog Retin Eye Res; 2009 Mar; 28(2):87-116. PubMed ID: 19071227
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA and cancer: Current status and prospective.
Wu W; Sun M; Zou GM; Chen J
Int J Cancer; 2007 Mar; 120(5):953-60. PubMed ID: 17163415
[TBL] [Abstract][Full Text] [Related]
26. Unique MicroRNA signature and clinical outcome of cancers.
Yu SL; Chen HY; Yang PC; Chen JJ
DNA Cell Biol; 2007 May; 26(5):283-92. PubMed ID: 17504024
[TBL] [Abstract][Full Text] [Related]
27. Biliary tract cancers: epidemiology, molecular pathogenesis and genetic risk associations.
Marcano-Bonilla L; Mohamed EA; Mounajjed T; Roberts LR
Chin Clin Oncol; 2016 Oct; 5(5):61. PubMed ID: 27829275
[TBL] [Abstract][Full Text] [Related]
28. [Pancreatic cancer and microRNAs].
Hwang JH
Korean J Gastroenterol; 2012 Jun; 59(6):395-400. PubMed ID: 22735871
[TBL] [Abstract][Full Text] [Related]
29. Targeting microRNAs to modulate TRAIL-induced apoptosis of cancer cells.
Lu T; Shao N; Ji C
Cancer Gene Ther; 2013 Jan; 20(1):33-7. PubMed ID: 23138871
[TBL] [Abstract][Full Text] [Related]
30. MicroRNAs in virus-induced tumorigenesis and IFN system.
Fiorucci G; Chiantore MV; Mangino G; Romeo G
Cytokine Growth Factor Rev; 2015 Apr; 26(2):183-94. PubMed ID: 25466647
[TBL] [Abstract][Full Text] [Related]
31. MicroRNAs and human cancer.
Nikitina EG; Urazova LN; Stegny VN
Exp Oncol; 2012; 34(1):2-8. PubMed ID: 22453141
[TBL] [Abstract][Full Text] [Related]
32. Non-coding RNAs as emerging molecular targets of gallbladder cancer.
Tekcham DS; Tiwari PK
Gene; 2016 Aug; 588(1):79-85. PubMed ID: 27131889
[TBL] [Abstract][Full Text] [Related]
33. MicroRNAs: novel biomarkers for lung cancer diagnosis, prediction and treatment.
Wang Q; Wang S; Wang H; Li P; Ma Z
Exp Biol Med (Maywood); 2012 Mar; 237(3):227-35. PubMed ID: 22345301
[TBL] [Abstract][Full Text] [Related]
34. The pathological role of microRNAs and inflammation in colon carcinogenesis.
Zhang L; Fan XM
Clin Res Hepatol Gastroenterol; 2015 Apr; 39(2):174-9. PubMed ID: 25154001
[TBL] [Abstract][Full Text] [Related]
35. MicroRNAs and cancer.
Cowland JB; Hother C; Grønbaek K
APMIS; 2007 Oct; 115(10):1090-106. PubMed ID: 18042145
[TBL] [Abstract][Full Text] [Related]
36. MicroRNAs as potential target gene in cancer gene therapy of gastrointestinal tumors.
Tazawa H; Kagawa S; Fujiwara T
Expert Opin Biol Ther; 2011 Feb; 11(2):145-55. PubMed ID: 21219233
[TBL] [Abstract][Full Text] [Related]
37. Diet, microRNAs and prostate cancer.
Saini S; Majid S; Dahiya R
Pharm Res; 2010 Jun; 27(6):1014-26. PubMed ID: 20221895
[TBL] [Abstract][Full Text] [Related]
38. [MicroRNAs and cancer-associated signal transduction pathways].
Wu YY; Li LJ
Yi Chuan; 2007 Dec; 29(12):1419-28. PubMed ID: 18065374
[TBL] [Abstract][Full Text] [Related]
39. miRNAs in pregnancy-related complications.
Lycoudi A; Mavreli D; Mavrou A; Papantoniou N; Kolialexi A
Expert Rev Mol Diagn; 2015; 15(8):999-1010. PubMed ID: 26051307
[TBL] [Abstract][Full Text] [Related]
40. The oncogenic and tumour suppressive roles of microRNAs in cancer and apoptosis.
Babashah S; Soleimani M
Eur J Cancer; 2011 May; 47(8):1127-37. PubMed ID: 21402473
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
